Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats. - Wikidata - wikimedia - TriplyDB

Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

http://www.wikidata.org/entity/Q42829690

about

(+/-)-Nantenine analogs as antagonists at human 5-HT(2A) receptors: C1 and flexible congeners Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.Serotonin transporter and receptor genes significantly impact nicotine dependence through genetic interactions in both European American and African American smokers Examination of the mechanism of action of two pre-quit pharmacotherapies for smoking cessation.Affinity of aporphines for the human 5-HT2A receptor: insights from homology modeling and molecular docking studies.IV nicotine self-administration in rats using a consummatory operant licking response: sensitivity to serotonergic, glutaminergic and histaminergic drugs.Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.D-cycloserine selectively decreases nicotine self-administration in rats with low baseline levels of response.Serotonergic mechanism underlying tranylcypromine enhancement of nicotine self-administration Differential effects of 5-HT(2A) and 5-HT(2C) receptor blockade on strategy-switching.Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats.Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on nicotine self-administration 5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function Amitifadine, a triple monoamine re-uptake inhibitor, reduces nicotine self-administration in female rats.Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's disease ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease.Mirtazapine and ketanserin alter preference for gambling-like schedules of reinforcement in rats.The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition.

P2860

Q24649697-FFF5D579-B426-485B-8535-75E6B2538ED5 Q30244252-BBA107E7-DFB2-4FF7-910D-E896479AA1C9 Q30413322-933ACC51-3FD7-464F-840B-A1B12D1597C4 Q33446364-EE6890DF-FD28-420F-A624-D074ABEED774 Q34052154-7C2F065B-C666-4751-B2B8-75E0CB406CFA Q34053998-4CAC78DC-F832-4267-A53E-CDA81A6C53C8 Q34407185-1C6C10FC-3CE4-4C50-A88F-CBB4A85F9913 Q34671760-2011CA31-8789-4887-9B27-158CE6F4E85E Q34758170-7AA67BB0-5A41-41F0-BFBA-EFEF20A573FB Q35040839-0426B7AD-673C-436E-BAC6-5D34E3C8346F Q35188133-1D5414D7-974E-4685-BF36-C039B1B11EDA Q35243269-75656A7E-74CB-41AB-B383-EBEFAF5124B9 Q36334398-D526C97A-F71D-4A4A-B2BB-DFEC0984EEC0 Q36936920-02C057B1-02D6-472D-BD75-10883BB7B6C9 Q37086977-A47F825A-824E-4C00-AFEB-2B606B6C8906 Q37209730-06C266B5-5761-467D-A536-A109EC56F221 Q37708588-1C4728C9-F785-4228-BDD7-FC08186CBDD0 Q38835538-67587796-68BC-4306-BD83-0A6CB8972B5D Q42207617-6C21C64D-4614-4E51-84FB-E936C72D59A5

P2860

Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

http://www.wikidata.org/entity/Q42829690

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

@en

Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

@nl

type

label

Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

@en

Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

@nl

prefLabel

Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

@en

Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

@nl

P1433

Q42829690-AA3C731C-19A9-4136-886D-06118B7A046C

P1476

Q42829690-52971F22-BD31-466C-8345-833D28F9E00E

P2093

Q42829690-24F8A6C6-20A6-4E28-9405-0401EA7E4E1A

Q42829690-2598FB2A-C240-419E-B7AB-73B7C72EC9B2

Q42829690-36319746-F9B0-4CF3-858C-91509D239226

Q42829690-43895453-F0E8-45B4-B7D4-C1D45EBF8978

Q42829690-6F19E63F-D769-4E70-BC50-40C690148EEA

Q42829690-9D193733-9CA4-4781-9D12-F90882409A6D

Q42829690-C9DD5429-551A-4AF1-9F8D-32D9B0C8F7E8

Q42829690-E3EEBF6C-C1A1-4D94-89B2-5B885FE651AC

P2860

Q42829690-08BEC1E7-53ED-4FFF-9553-86709076FFB7

Q42829690-0EA44D11-11F4-43BC-97B2-A3BDE6A47647

Q42829690-1303AD18-F293-47AC-8F82-C9917A71527E

Q42829690-1F9176E5-7E5C-4EB6-9549-BCA35C298552

Q42829690-26D450FB-F257-405D-98E2-48339819450F

Q42829690-349E7791-67B8-4C36-9ADD-72CB86E6090C

Q42829690-37D08826-2C67-4214-901C-A9CC71BFCFD8

Q42829690-4232E350-F0E9-4A92-998E-528550CFFD5A

Q42829690-44C76DE0-F9DF-4140-AB95-8DA02CE23E51

Q42829690-8C57C9BD-F6EB-4896-BA4F-5E2343C9088D

P304

Q42829690-A39720D9-F3DA-4CC4-934F-AF5A38AC327A

P31

Q42829690-4ABE225B-FC6E-4113-94B5-9C2FFF0EDBF9

P356

Q42829690-C3B77923-F68B-42F4-B0CD-48C24BAD4BB9

P407

Q42829690-3DB24B1B-6E7F-4888-B051-F3B398AD7F43

P433

Q42829690-878362AE-B7E4-4BEF-B977-DFAE79235BE1

P478

Q42829690-023B7543-C154-4D28-B2E3-B8AA11E35C2A

P577

Q42829690-6DB1CFEE-E1AC-4960-9066-C95424A6F542

P5875

Q42829690-FD55A27E-6954-4A32-9D9B-C040365657B5

P698

Q42829690-0D07D293-FF93-47CC-9720-2931C21E9212

P921

Q42829690-8F59709B-56C9-4B2E-8887-D1B76EA1324F

P932

Q42829690-F2428030-7FA9-45A9-B61F-FBFFE9AA7D0A

P356

J.EJPHAR.2008.10.016

P1433

European Journal of Pharmacology

P1476

Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.

@en

P2093

Amir H Rezvani

http://www.w3.org/2001/XMLSchema#string

Ann Petro

http://www.w3.org/2001/XMLSchema#string

Edward D Levin

http://www.w3.org/2001/XMLSchema#string

Jed E Rose

http://www.w3.org/2001/XMLSchema#string

Kofi Horton

http://www.w3.org/2001/XMLSchema#string

Michael Johnson

http://www.w3.org/2001/XMLSchema#string

Paul Williams

http://www.w3.org/2001/XMLSchema#string

Susan Slade

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of smoking among psychiatric outpatients

The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination

The role of the striatopallidal and extended amygdala systems in drug addiction.

Role of dopamine in the behavioural actions of nicotine related to addiction.

Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125743.

Dopamine and drug addiction: the nucleus accumbens shell connection.

Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.

Role of serotonin(2C) receptors in the control of brain dopaminergic function.

Involvement of serotonin in nicotine dependence: processes relevant to positive and negative regulation of drug intake.

Nicotinic--serotonergic interactions in brain and behaviour.

P304

93-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EJPHAR.2008.10.016

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

600

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23413923

http://www.w3.org/2001/XMLSchema#string

P698

18950618

http://www.w3.org/2001/XMLSchema#string

P921

P932

2638587

http://www.w3.org/2001/XMLSchema#string